1. Healy D. The antidepressant drama. In: Weisman MM, editor. Treatment of depression: bridging the 21st century. Washington, DC: American Psychiatric Press; 2001.
2. Rogers SC, Clay PM. A statistical review of controlled trials of imipramine and placebo in the treatment of depressive illnesses. Br J Psychiatry. 1975;127:599–603. [PubMed]
3. Fink PJ, Tasman A. The stigma of electroconvulsive therapy: A workshop. In: Fink PJ, Tasman A, editors. Stigma and mental Illness. Washington, DC: American Psychiatric Press; 1992. pp. 189–201.
4. Reiter-Theil S. Autonomy and beneficence: Ethical issues in electroconvulsive therapy. Convuls Ther. 1992;8:237–244. [PubMed]
5. American Psychiatric Association Task Force on ECT. Washington, DC: American Psychiatric Association; 1978. Electroconvulsive therapy (Task Force Report # 14)
6. Lebensohn ZM. Electroconvulsive therapy: Psychiatry’s villain or hero? Am J Soc Psychiatry. 1984;4:39–43.
7. Endler NS. A holiday of darkness: A psychologist’s personal journal out of his depression. Toronto: Wall & Thompson; 1990.
8. Payne NA, Prudic J. Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract. 2009;15:348–368. [PMC free article] [PubMed]
9. Shorter E, Healy D. Shock therapy: A history of electroconvulsive treatment in mental illness. Rutgers: Rutgers University Press; 2007.
10. Ottosson JO, Fink M. Ethics in electroconvulsive therapy. New York: Brunner-Routledge; 2004.
11. Senter NW, Winslade WJ, Liston EH, et al. Electroconvulsive therapy: The evolution of legal regulation. Am J Soc Psychiatry. 1984;4:11–15.
12. American Psychiatric Association. second edition. Washington, DC: American Psychiatric Press; 2001. The practice of ECT: Recommendations for treatment, training and privileging.
13. Andrews M, Hasking P. Effect of two educational interventions on knowledge and attitudes towards electroconvulsive therapy. J ECT. 2004;29:230–236. [PubMed] 14. Pettinati HM, Tamburello TA, Ruetsch CR, et al. Patient attitudes toward electroconvulsive therapy. Psychopharmacol Bull. 1994;30:471–475. [PubMed] 15. Dowman J, Pate A, Rajput K. Electroconvulsive therapy: Attitudes and misconceptions. J ECT. 2005;21:84–86. [PubMed] 16. Brodkey AC. The role of the pharmaceutical industry in teaching psychopharmacology: A growing problem. Acad Psychiatry. 2005;29:222–229. [PubMed] 17. Hirshbein L, Sarvananda S. History, power and electricity: American popular magazine accounts of electroconvulsive therapy, 1940–2005. J Hist Behav Sci. 2008;44:1–18. [PubMed]
18. Dukakis K, Tye L. Shock: The healing power of electroconvulsive therapy. New York: Penguin; 2006.
19. Endler NS, Persad E. Electroconvulsive therapy: The myths and the realities. Toronto: Hans Huber; 1988.
20. Cauchon D. Controversy and questions—Shock therapy—patients often aren’t informed of full danger. USA Today. 1995 December 6;:1A. 4D, 6D.
21. Sackeim H, Prudic J, Fuller R, et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32:244–254. [PubMed] 22. Shiwach RS, Reid W, Carmody TJ. An analysis of reported deaths following electroconvulsive therapy in Texas, 1993–98. Psychiatr Serv. 2001;52:1095–1097. [PubMed]
23. Reid W. Don’t malign treatment. USA Today. 1995 December 8;:12A.
24. News and Notes. Dick Cavett and ECT. Convuls Ther. 1992;8:300–301.
25. Fink M. Electroshock: Restoring the mind. New York: Oxford University Press; 1999.
26. McDonald A, Walter G. The portrayal of ECT in American movies. J ECT. 2001;17:264–274. [PubMed] 27. Walter G, McDonald A, Rey JM, et al. Medical student knowledge and attitudes regarding ECT prior to and after viewing ECT scenes from movies. J ECT. 2002;18:43–46. [PubMed]
28. Abrams R. Electroconvulsive therapy, 3rd edition. New York: Oxford University Press; 2002.
29. Kramer BA. The use of ECT in California revisited, 1984–1994. J ECT. 1999;15:245–251. [PubMed] 30. Winslade WJ, Liston EH, Ross JW, et al. Medical, judicial, and statutory regulation of ECT in the United States. Am J Psychiatry. 1984;141:1349–1355. [PubMed]
31. Szasz T. The myth of mental illness: Foundations of a theory of personal conduct. New York: Harper & Row; 1974.
32. Breggin P. Toxic psychiatry: Why therapy, empathy and love must replace the drugs, electroshock, and biochemical theories of the ‘New Psychiatry.’. New York: St. Martin’s Press; 1991.
33. Goffman E. Asylums: Essays on the social situation of mental patients and other inmates. New York: Doubleday; 1961.
34. National Institute of Mental Health Consensus Development Panel: Mood disorders: Pharmacologic prevention of recurrences. Am J. Psychiatry. 1985;142:469–476. [PubMed]
35. American Psychiatric Association: The Practice of ECT: Recommendations for treatment, training, and privileging. Washington DC: American Psychiatric Press; 1990.
36. Gomez J. Subjective side effects of ECT. Br J Psychiatry. 1975;127:609–611. [PubMed] 37. Freeman CP, Kendell RE. ECT I: Patients’ experiences and attitudes. Br J Psychiatry. 1980;137:8–16. [PubMed] 38. Hughes J, Barraclough BM, Reeve W. Are patients shocked by ECT? J R Soc Med. 1981;74:283–285. [PMC free article] [PubMed] 39. Benbow SM. Patients’ views on electroconvulsive therapy on completion of a course of treatment. Convuls Ther. 1988;4:146–152. [PubMed] 40. Janicak PG, Mask J, Trimakas KA, et al. ECT: An assessment of mental health professionals’ knowledge and attitudes. J Clin Psychiatry. 1985;46:262–266. [PubMed] 41. Pippard J, Ellam L. Electroconvulsive treatment in Great Britain. Br J Psychiatry. 1981;139:563–568. [PubMed] 42. Kalayam B, Steinhart MJ. A survey of attitudes on the use of electroconvulsive therapy. Hosp Community Psychiatry. 1981;32:185–187. [PubMed]
43. Lutchman RD, Stevens T, Bashir A, et al. Mental health professionals’ attitudes towards and knowledge of electroconvulsive therapy. J Ment Health. 2001;10:141–150.
44. Szuba MP, Guze BH, Liston EH, et al. Psychiatry resident and medical student perspectives on ECT: Influence of exposure and education. Convuls Ther. 1992;8:110–117. [PubMed] 45. Dillon P. Electroconvulsive therapy patient/family education. Convuls Ther. 1995;11:188–191. [PubMed]
46. Weiner RD, Coffey CE. When ECT is recommended for your patient. Med Aspects Hum Sex. 1988 June;:20–24.
47. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278–296. [PubMed] 48. Nelmes M. Preoperative teaching helps reduce anxiety. Dimens Health Serv. 1989;66:23–25. [PubMed] 49. Nyamathi A, Kashiwabara A. Preoperative anxiety: Its effect on cognitive thinking. AORN J. 1988;47:164–169. [PubMed] 50. Davis L, Rosenthal GT, Soper B. Structuring and anxiety reduction prior to myelography. Psychol Rep. 1990;66:1171–1176. [PubMed] 51. Wilkinson D, Daoud J. The stigma and enigma of ECT. Int J Geriatr Psychiatry. 1998;13:833–835. [PubMed]
52. Lukens EP, Thorning H. Psychoeducation and severe mental illness: Implications for social work practice and research. In: Williams JBW, Ell K, editors. Advances in mental health research: Implications for practice. Washington, DC: NASW Press; 1998.
53. Baxter LR, Roy-Byrne P, Liston EH, et al. Informing patients about electroconvulsive therapy: Effects of a videotape presentation. Convuls Ther. 1986;2:25–29. [PubMed]
54. Jenaway A. Educating patients and relatives about electroconvulsive therapy: The use of an information leaflet. Psychiatr Bull. 1993;17:10–12.
55. Fox H. Patients’ fear of and objection to electroconvulsive therapy. Hosp Community Psychiatry. 1993;44:357–360. [PubMed]
56. Hepworth DH, Rooney RH, Rooney GD, et al. Direct social work practice: Theory and skills, 5th edition. Belmont, CA: Thomson Brooks/Cole; 2006.
57. Deegan P. Recovery as a self-directed process of healing and transformation. In: Brown C, editor. Recovery and wellness: Models of hope and empowerment for people with mental illness. New York: Haworth Press; 2001. pp. 5–22.
58. Hepworth DH, Rooney RH, Larsen J. Direct social work practice: Theory and skills, 5th edition. Pacific Grove, CA: Brooks/Cole Publishing; 1997.
59. Rosen LE, Amodor XF. When someone you love is depressed: How to help your loved one without losing yourself. New York: Free Press; 1996.
60. Guy W. Rockville, MD: U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976. ECDEU assessment manual for psychopharmacology-revised (DHEW Publ. No ADM 76-338) pp. 218–222.
61. Endicott J, Cohen J, Nee J, et al. Hamilton depression rating scale. Extracted from regular and change versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry. 1981;38:98–103. [PubMed]
62. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000.
63. Kellner CH, Knapp RG, Petrides G, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: A multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE) Arch Gen Psychiatry. 2006;63:1337–1344. [PubMed]
64. Üstün TB. The worldwide burden of depression in the 21st century. In: Weissman MM, editor. Treatment of depression: Bridging the 21st century. Washington DC: American Psychiatric Press; 2001. pp. 35–45.
65. Giles DE, Jarrett RB, Biggs MM, et al. Clinical predictors of recurrence in depression. Am J Psychiatry. 1989;146:764–767. [PubMed] 66. Belsher G, Costello CG. Relapse after recovery from unipolar depression: A critical review. Psychol Bull. 1988;104:84–96. [PubMed] 67. Bourgon LN, Kellner CH. Relapse of depression after ECT: A review. J ECT. 2000;16:19–31. [PubMed] 68. Prudic J, Sackeim HA, Devanand DP. Medication resistance and clinical response to electroconvulsive therapy. Psychiatr Res. 1990;31:287–296. [PubMed]
69. Prudic JM, Sackeim HA, Rifas S. Medication resistance, response to ECT, and prevention of relapse. Psychiatr Ann. 1994;24:228–231.
70. Sackeim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol. 1990;10:96–104. [PubMed] 71. Keitner GI, Ryan CE, Miller IW, et al. Recovery and major depression: Factors associated with twelve-month outcome. Am J Psychiatry. 1992;149:93–99. [PubMed] 72. Keitner GI, Ryan CE, Miller IW, et al. Role of the family in recovery and major depression. Am J Psychiatry. 1995;152:1002–1008. [PubMed] 73. Hooley JM, Orley J, Teasdale JD. Levels of expressed emotion and relapse in depressed patients. Br J Psychiatry. 1986;148:642–647. [PubMed] 74. Veiel HOF, Kuhner C. Relatives and depressive relapse: The critical period after discharge from inpatient treatment. Psychol Med. 1990;20:977–984. [PubMed] 75. Whisman MA, Bruce ML. Marital dissatisfaction and incidence of major depressive episode in a community sample. J Abnorm Psychol. 1999;108:674–678. [PubMed]
76. Whisman MA. The association between depression and marital dissatisfaction. In: Beach SRH, editor. Marital and family process in depression: A scientific foundation for clinical practice. Washington DC: American Psychological Association; 2001. pp. 3–24.
77. Whiffen VE. Disentangling causality in the associations between couple and family processes and depression. In: Pinsof WM, Lebow JL, editors. Family psychology: The art of the science. New York: Oxford University Press; 2005. pp. 375–395.
78. Barnett PA, Gotlib IH. Psychosocial functioning and depression: Distinguishing among antecedents, concomitants, and consequences. Psychol Bull. 1988;104:97–126. [PubMed]
79. Thase ME. The roles of psychosocial factors and psychotherapy in refractory depression: Missing pieces in the puzzle of treatment resistance? In: Nolen WA, Zohar J, Roose SP, et al., editors. Refractory depression: Current strategies and future directions. New York: John Wiley and Sons; 1994.
80. DeBattista C, Mueller K. Is electroconvulsive therapy effective for the depressed patients with comorbid personality disorder? J ECT. 2001;17:91–98. [PubMed] 81. Black DW, Bell S, Hulbert J, et al. The importance of Axis II in patients with major depression: A controlled study. J Affect Disord. 1988;14:115–122. [PubMed] 82. Pfohl B, Stangl D, Zimmerman M. The implications of DSM-III personality disorders for patients with major depression. J Affect Disord. 1984;7:309–318. [PubMed] 83. Pilkonis PA, Frank E. Personality pathology in recurrent depression: Nature, prevalence, and relationship to treatment response. Am J Psychiatry. 1988;145:435–441. [PubMed] 84. Shea MT, Pilkonis PA, Beckham E, et al. Personality disorders and treatment outcome in the NIMH treatment of depression collaborative research program. Am J Psychiatry. 1990;147:711–718. [PubMed] 85. Torgerson AR. Personality and personality disorders predict development and relapses of major depression. Acta Psychiatr Scand. 1997;95:336–342. [PubMed] 86. Gunderson JG, Morey LC, Stout RL, et al. Major depressive disorder and borderline personality disorder revisited: Longitudinal interactions. J Clin Psychiatry. 2004;65:1049–1056. [PubMed] 87. Zimmerman M, Coryell W, Pfohl B, et al. ECT response in depressed patients with and without a DSM-III personality disorder. Am J Psychiatry. 1986;143:1030–1032. [PubMed] 88. Kramer BA. Poor response to electroconvulsive therapy in patients with a combined diagnosis of major depression and borderline personality disorder. The Lancet. 1982;2(8306):1048. [PubMed] 89. Sareen J, Murray E, Guertin J. The impact of clinically diagnosed personality disorders on acute and one-year outcomes of electroconvulsive therapy. J ECT. 2000;16:43–51. [PubMed] 90. Prudic J, Olfson M, Marcus SC, et al. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry. 2004;55:301–312. [PubMed] 91. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med. 2000;160:2101–2107. [PubMed] 92. Kay DWK, Kahy T, Garside RF. A 7-month double blind trial of amitriptyline and diazepam in ECT-treated patients. Br J Psychiatry. 1970;117:667–671. [PubMed] 93. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: A randomized controlled trial. JAMA. 2001;285:1299–1307. [PubMed] 94. van den Broek WW, Birkenhäger TK, Mulder PG, et al. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: A randomized, placebo-controlled trial. J Clin Psychiatry. 2006;67:263–268. [PubMed] 95. Rabheru K, Persad E. A review of continuation and maintenance electroconvulsive therapy. Can J Psychiatry. 1997;42:476–484. [PubMed] 96. Sackeim H. Continuation therapy following ECT: Directions for future research. Psychopharmacol Bull. 1994;30:501–521. [PubMed]
97. Sackeim H, Lisanby S. Physical treatments in psychiatry. In: Weissman MM, editor. Treatment of depression: Bridging the 21st century. Washington DC: American Psychiatric Press; 2001. pp. 151–174.